Table 2.

Schedule of enrollment, interventions, and assessments

Study period	Pre-treatment	Treatment			Follow-up
Timepoint (weeks)	<− 2	0	6	12	24	36
Enrollment
Informed consent	X
Eligibility assessment	X
Baseline variables		X
Allocation		X
Interventions
CCFES		◊------	-------------	------◊
cNMES		◊------	-------------	------◊
TOT		◊------	-------------	------◊
Assessments
End of Treatment Questionnaire				X
SIS – Hand Section		X		X		X
Neuro-QOL UE Function		X		X		X
Modified Ashworth Scale		X	X	X	X	X
UEFM		X	X	X	X	X
BBT		X	X	X	X	X
SULCS		X	X	X	X	X
ARAT		X	X	X	X	X
MEP excitability		X		X		X
Ipsilateral MEP excitability		X		X		X
Interhemispheric inhibition		X		X		X

CCFES contralaterally controlled functional electrical stimulation, cNMES cyclic neuromuscular electrical stimulation, TOT task-oriented-training, SIS stroke impact scale, QOL quality of life, UE upper extremity, UEFM upper extremity Fugl-Meyer assessment, BBT box and blocks test, SULCS stroke upper limb capacity scale, ARAT action research arm test, MEP motor evoked potential